| 中文名称 | ((R)-1-环己基-2-((S)-2-((4-(N-羟基氨基甲酰胺基)苄基)氨基甲酰)壬苷-1-基)-2-氧乙基)甘氨酸乙酯 |
|---|---|
| 中文别名 | 希美加群;Ximelagatran 抑制剂;三环己基膦[1,3-双(2,4,6-三甲基苯基)-4,5-二氢咪唑-2-亚基][(苯硫基)亚甲基]钌(II)二氯 |
| 英文名称 | Ethyl ((R)-1-cyclohexyl-2-((S)-2-((4-(N-hydroxycarbamimidoyl)benzyl)carbamoyl)azetidin-1-yl)-2-oxoethyl)glycinate |
| 英文别名 | Glycine,N-[(1R)-1-cyclohexyl-2-[(2S)-2-[[[[4-[(hydroxyamino)iminomethyl]phenyl]methyl]amino]carbonyl]-1-azetidinyl]-2-oxoethyl]-,ethyl ester;EXANTA;ethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxoethyl]amino]acetate;Glycine,N-[(1R)-1-cyclohexyl-2-[(2S)-2-[[[[4-[(hydroxyamino)iminomethyl]phenyl]methyl]amino]ca...;Glycine,N-[(1R)-1-cyclohexyl-2-[(2S)-2-[[[[4-[(hydroxyamino)iminomethyl]phenyl]methyl]amino]carbonyl]-1-azetidinyl]-2-oxoethy;Ximelagatran;Ximelagatran;[14C]-Ximelagatran;[3H]-Ximelagatran;Exanta (TN);Exarta;H 376;USAN;ximelagatra;Ximelagatran [USAN:INN];N-[(1R)-1-Cyclohexyl-2-[(2S)-2-[[[[4-[(hydroxyamino)iminomethyl]phenyl]methyl]amino]carbonyl]-1-azetidinyl]-2-oxoethyl]-glycine ethyl ester;N-[(1R)-1-Cyclohexyl-2-[(2S)-2-[[[[4-[(hydroxyamino)iminomethyl]phenyl]methyl]amino]carbonyl]-1-azetidinyl]-2-oxoethyl]glycine ethyl ester;XIMELEGATRAN;Exanta (XiMelagatran);Ethyl 2-[[(1R)-1-Cyclohexyl-2-[(2S)-2-[[4-(N'-Hydroxycarbamimidoyl)Phenyl]Methylcarbamoyl]Azetidin-1-Yl]-2-Oxoethyl]Amino]Acetate Ximelagatran;Ethyl 2-[[(1R)-1-Cyclohexyl-2-[(2S)-2-[[4-(N'-Hydroxycarbamimidoyl)Phenyl]Methylcarbamoyl]Azetidin-1-Yl]-2-Oxoethyl]Amino]Acetate Ethyl 2-[[(1R)-1-Cyclohexyl-2-[(2S)-2-[[4-(N'-Hydroxycarbamimidoyl)Phenyl]Methylcarbamoyl]Azetidin-1-Yl]-2-Oxo-Ethyl |
| CAS号 | 192939-46-1 |
| 分子式 | C24H35N5O5 |
| 分子量 | 473.57 |
微信公众号
版权所有：济南迈纳科技有限公司 未经授权禁止拷贝本站资料，如有违反,将追究法律责任
备案号： 鲁ICP备2021031564号-1 危险品化学品经营许可证 营业执照
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
